Posted in | News | Nanotoxicology | Nanobusiness

Summit Focuses on Environmentally Responsible Development of Nanotechnology

The Triangle was recently ranked as the No. 4 "Nano Metro" in the United States by the Project on Emerging Nanotechnologies, trailing only Boston, San Francisco and San Jose.

The Research Triangle Environmental Health Collaborative (The Collaborative) will gather 150 experts from around the nation at its second annual environmental health summit on October 8-9, 2009. The summit will be held at the North Carolina Biotechnology Center in North Carolina's Research Triangle Park and focus on Environmentally Responsible Development of Nanotechnology.

The Triangle's “Nano Metro” ranking is based largely on the number of companies and universities investigating nanotechnology, including Duke University's Center for the Environmental Implications of NanoTechnlogy (CEINT), North Carolina State University's Nanotechnology Initiative and UNC-Chapel Hill's Carolina Center of Cancer Nanotechnology Excellence, as well as numerous other nanotech programs. Private companies located in the region like Liquidia are developing ways to use nanoparticles to better deliver cancer drugs. The global market for nanotech goods is expected to grow from about $147 billion in 2007 to $3.1 trillion in 2015, according to Lux Research.

This year's summit will feature a broad and experienced group of participants representing wide areas of expertise and diverse views from their leadership in Federal, State, and local governments; academia, industry, and public interest organizations.

“The Research Triangle region has become the epicenter for contemporary thinking about environmental health, and the Collaborative provides a neutral forum to host candid discussions and to provide advice on the most significant issues facing environmental health and related public policy,” said Collaborative chairman Ken Olden, former director of the National Institute of Environmental Health Sciences. “There are still many unknowns about the environmental impact of nanotechnology locally, as well as around the world, and we have many experts in our region focused on various solutions.”

This is the second summit presented by The Collaborative, and will identify critical issues in nano-enabled product development and manufacturing and explore the nanomanufacturing landscape; so that businesses can overcome barriers to success related to environmental/occupational health concerns. The outcome of this meeting will be a guidance document to highlight these critical issues and provide business and policymakers with recommendations about how to successfully address them.

Mark Wiesner (Duke's CEINT) will kick off the two-day event outlining various nanotechnology challenges, followed by keynotes from Chad Holliday (Chairman of the Board and former CEO of DuPont, Inc.) offering the industry perspective, Joe DeSimone (UNC-Chapel Hill/NCSU/Liquidia) explaining a bench to market process and Jo Anne Shatkin (CLF Ventures) presenting the life cycle approach to risk analysis.

James Bonner (NCSU), Brad Brooks (IBM), Jie Liu (Duke) and Gregory Parson (NCSU) will lead a work group about Nanomaterials Fabrication.

Lynn L. Bergeson (Bergeson & Campbell), Jurron Bradley (Lux Research), Nancy A. Monteiro-Riviere (NCSU) and Michele Ostraat (RTI International) will discuss Nanomaterials Integration into Products.

Steve Beaulieu (RTI International), David Berube (NCSU), Stephen Klaine (Clemson University) and Nigel Walker (National Institute of Environmental Health Sciences) will talk about Nanomaterials Disposal and End of Life Issues.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.